Ryan Choi has long been involved in Hong Kong capital markets, with over a decade of extensive experience in Hong Kong initial public offerings, secondary listings, post-listing compliance, mergers and acquisitions, overseas bond issuances, and other corporate transactions. 

Before joining JunHe, Mr. Choi was a partner at Kirkland & Ellis LLP, and he has also worked at the Hong Kong offices of Sidley Austin LLP and Loeb & Loeb LLP.

Mr. Choi has participated in several landmark Hong Kong IPO projects, including Muyuan Foods (the world’s largest hog farming company), Shanghai Iluvatar (a leading company in China’s general GPU industry), ZG Group (the first company from Mainland China to list in Hong Kong via the De-SPAC model), and Beijing Airdoc Technology (one of the first AI-empowered biotech company from mainland China listed in Hong Kong). Other representative transactions include the global offering and listing projects of Dida Inc., Tanwan Inc., ADICON Holdings, Nayuki Holdings, Everest Medicines and Fosun Tourism Group; the secondary listing projects of 360 DigiTech and Noah Holdings); as well as the various issuances of USD senior notes, convertible bond issuances and related debt financings by Wynn Macau, Limited. In cross-border mergers and complex transactions, he represented NetDragon in the spinning off of its overseas education business for listing on NYSE, which was selected as a “Deal of the Year'” by China Business Law Journal.